Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

61.77 +0.28 (+0.46%)
Official Closing Price Updated: 7:00 PM EDT, Aug 9, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,004,642
Open 61.68
Bid (Size) 55.00 (1)
Ask (Size) 65.00 (1)
Prev. Close 61.49
Today's Range 61.50 - 62.23
52wk Range 45.85 - 64.53
Shares Outstanding 290,441,408
Dividend Yield 3.15%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Equity Index Futures Slightly Higher As U.S. Dollar Retreats
(Monday Market Open) Equity index futures pointed to a higher open as the U.S. dollar retreated from Friday’s rally. 
Via Benzinga
A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
(Thursday Market Open) The Bank of England (BoE) raised its key lending rate by 50 basis points, its biggest hike in 27 years. 
Via Benzinga

Performance

YTD
+18.77%
+18.77%
1 Month
+16.57%
+16.57%
3 Month
+10.21%
+10.21%
6 Month
+14.07%
+14.07%
1 Year
+21.83%
+21.83%

More News

Read More
Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings
Via Benzinga
Cardinal Health: Q3 Earnings Insights
Via Benzinga
Recession Investing: 5 High Yield Dividend Stocks For A Downturn
Via Benzinga
McDonald's Bolsters Digital Vision With New Senior Appointment
Via Benzinga
RxLive Raises $5 Million Series A to Deliver Population Health Telepharmacy Solutions for At-Risk Patients
From RxLive
Via Globe NewsWire
Cardinal Health Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
Via Investor's Business Daily
Why McKesson Just Added To Its 33% Year-To-Date Gain With A Brief Breakout
Via Investor's Business Daily
What 4 Analyst Ratings Have To Say About Cardinal Health
Via Benzinga
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
Via Benzinga
Is J&J Stock A Buy On Its Recent Spate Of Positive Cancer News?
Via Investor's Business Daily
Benzinga Before The Bell: Record Inflows In 'Short Bitcoin' Funds, Elon Mus's Trillionaire Possibility, Gmail's Political Bias And Other Top Financial Stories Tuesday, July 5
Via Benzinga
Federal Judge Says McKesson, AmerisourceBergen, Cardinal Health Not Responsible For Opioid Epidemic: Report
Via Benzinga
Quant Ratings Updated on 97 Stocks
Via InvestorPlace
SciSparc And Polyrizon Report Joining Forces To Develop A Non-Opioid Pain Relief Nasal Spray
Via Benzinga
7 High-Yield Retirement Stocks to Buy for Your Nest Egg
Via InvestorPlace
7 Beaten-Down Growth Stocks That Look Like Big Bargains Right Now
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022
Via Benzinga
The 7 Highest-Yielding Dividend Stocks to Buy Now for Income
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022
Via Benzinga
Dividend Income Update April 2022
Via Talk Markets
7 Stock Picks to Play the Post-Pandemic Return of Dental Visits
Via InvestorPlace
Walgreens Announces $683M Opioid Settlement With Florida
Via Benzinga
Washington, Drug Distributors Reach $518M Settlement For Opioid Claims
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.